Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Shaftesbury Capital reports solid first-half results

(Sharecast News) - Shaftesbury Capital reported a solid set of interim results for the first half of 2025 on Tuesday, demonstrating continued growth across rents, earnings, valuations, and dividends. The FTSE 250 company's West End portfolio remained active and vibrant, the board said, with high footfall and seven-day-a-week trading, driving leasing demand and strong financial performance.

It said it completed 193 leasing transactions in the half-year, representing £19.2m in contracted rent, which was 9% ahead of the December estimated rental value (ERV) and 16.3% above previous passing rents.

Occupancy rates remain high, with just 2.4% of ERV available to let.

Footfall and customer sales across Shaftesbury's prime West End portfolio showed positive trends.

Shaftesbury's portfolio valuation increased 3.1% to £5.2bn, driven by a 2.9% like-for-like increase in ERV, which now stands at £261m.

The equivalent yield remained stable at 4.46%, while the company's EPRA net tangible assets grew by 3.3% to 206.8p per share.

Underlying earnings per share increased 16% to 2.2p, while the interim dividend was raised by 11.8% to 1.9p per share.

Capital expenditure and acquisitions continued to be a focus, with £71m invested in the portfolio.

That included a £2.7bn long-term partnership with Norges Bank Investment Management (NBIM) in April, focused on the Covent Garden estate.

The company's access to significant liquidity and a low leverage ratio left it well-positioned for future growth and market opportunities.

Key financial highlights included a gross profit of £89.2m, up from £80.7m in the first six months of 2024, and a strong profit for the period of £173m, more than doubling the £86.1m reported last year.

Basic earnings per share increased to 8.3p, up from 4.7p in the prior year.

The total shareholder return reached 26.1%, compared to just 2.0% in the first half of 2024, reflecting robust performance and positive market conditions.

"We are delighted to deliver continued strong performance, with growth in rents, earnings, dividends, valuation, and EPRA NTA," said Ian Hawksworth, chief executive.

"Our West End portfolio continues to be busy and vibrant with high footfall and strong leasing demand.

"We enter the second half of the year with positive momentum, supported by a strong balance sheet and access to liquidity, positioning us well to take advantage of market opportunities."

Looking ahead, Shaftesbury said it was confident in its ability to continue delivering growth, supported by its strong portfolio, market position, and strategic investments.

The company's outlook for the full year remained positive, with a solid foundation for continued success in the second half of 2025.

At 0936 BST, shares in Shaftesbury Capital were up 2.5% at 159.7p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.